ABION BIO, a Korea-based biopharmaceutical company, said it has entered into a licensing and co-development agreement worth ...

Despite the rapid growth of Korea’s biopharmaceutical market, the government's approval system to support it still relies on ...

ABL Bio has built a new headquarters in Gangnam, Seoul, anchoring its "Vision ABL 2.0."In an interview with Korea Biomedical ...

AstraZeneca Korea is expanding the therapeutic footprint of its PARP inhibitor Lynparza (ingredient: olaparib) in gynecologic ...

Just two months after German pharma Boehringer Ingelheim secured long-delayed reimbursement for Ofev in Korea, generics are ...

Inventage Lab unveiled its next-generation obesity drug platform technology in a poster presentation at the American Diabetes ...

Calls are growing to establish a new public medical school in South Jeolla Province, as promised by President Lee Jae ...

Korea’s Vaxcellbio is joining the next wave of cell therapy contenders, backed by a government grant and a platform it says ...

The mortality rate after acute myocardial infarction (AMI) was found to be higher among self-employed insured individuals ...

The Ministry of Food and Drug Safety has approved an expanded indication for Vemlidy (ingredient: tenofovir alafenamide), ...

Siemens Healthineers Korea has signed a strategic memorandum of understanding (MOU) with Phantomics, a Korean cardiac imaging ...

The rift among resigned doctors has been widening since the new government took office.A day after Park Dan, head of the ...